IDH1 and glioma: To our knowledge, the status of IDH1 mutation, MGMT promoter methylation, and 1p19q codeletion have a significant impact on the prognosis of glioma and this conclusion also applies to pGBM.16–18 However, we found that these key molecular markers did not have similar prognostic value in sGBM (Table 1).